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Summary.-Polyamines, such as putrescine and spermine, are naturally occurring
substances intimately associated with normal and neoplastic growth. High levels are
found in cancer patients and are associated with tumour growth. Experiments with
V79 hamster cells cultured in vitro have demonstrated that the presence ofputrescine
and spermine can significantly reduce the cytotoxicity of the commonly used chemo-
therapy agent cis-DDP. These data may have clinical implications.
POLYAMINES occur naturally in all
living organisms, and are intimately asso-
ciated with growth whether normal or
neoplastic (Ham, 1964; Duffy et al., 1971).
Raised levels ofpolyamines are associated
with cell growth, such as embryogenesis,
heptatic regeneration, and lactation, as
well as solid and haematological tumours
(Hospattankar et al., 1980). Their exist-
ence has been known for several years, but
it is their function as growth promoters
that has most recently raised interest as to
their possible association with neoplastic
processes (Russell, 1973). The findings,
first by Russell (1971) and then others
(Harik & Sutton, 1979; Marton etal., 1973)
that polyamine levels are raised in the
urine and sera of cancer patients, have
singled them out as potential biochemical
markers for cancer detection. The fluctu-
ations in levels ofpolyamines found during
malignancy reflect pathological changes,
and variations in their concentrations may
be used to determine a patient's response
to radiation or chemotherapy (Durie et al.,
1977; Russell et al., 1975). The presence of
polyamines and their regulating enzymes
during the cancer process appear to be
intimately related. This is further sup-
ported by the work ofO'Brien & Diamond
(1977) who showed that increased levels
of polyamines were intrinsic to tumour
promotion in vitro, and suggested that
normal and transformed cells differ in
their control ofpolyamine biosynthesis.
Among the naturally occurring poly-
amines, putrescine, spermine and sperm-
idine are best known. Their increase dur-
ing growth and differentiation usually
precede increases in RNA, DNA and pro-
tein synthesis. Putrescine, in elevated
amounts, appears to be related to the
growth fraction of a tumour and ele-
vated levels of spermidine to the cell-loss
factor.
The fact that polyamines can influence
cancer therapy has already been shown
with hyperthermia, where their presence
increases heat-mediated cell death (Ben
Hur & Rikils, 1979; Gerner & Russell,
1977). It seemed relevant and pertinent,
therefore, to ask whether the polyamines
could likewise modify the action of
antineoplastic chemotherapy agents. cis-
Diamminedichloroplatinum was chosen
for this study, a drug commonly used in
clinical practice for the treatment of
various testicular and bladder carcinomas,
as well as tumours of the head and neck
(Heydron, 1979).ClS-DDP ANTD POLYAMINES ON CELLS IN CULTURE
AIATERIALS AND METHODS
Culture of the cells.-Chinese hamster V79
cells wrere used in standard culture tech-
niques, the cells being grown in GIBCO FIO
culture medium supplemented with 10%0
foetal calf serum and antibiotics except for
experiments in which spermine was used, and
the media was then free of foetal calf serum.
Routine growth curves indicated a population
doubling time of , 10 h. For all experiments
cells were harvested from stock cultures by
trypsinization and counted with an electronic
particle counter (Coulter Electronics, Hialeah,
Florida). After appropriate dilutions, suffi-
cient cells were inoculated into 25cm2 Flacon
plastic tissue-culture flasks so that an esti-
mated 100 viable cells per flask would survive
the planned drug treatment. The number of
cells per flask was limited to the range where
the surviving fraction was not influenced by
the size of the inoculum. Cells plated in the
late afternoon were treated with drug com-
binations the following morning, the interval
alloNwing cells to attach and enter an ex-
ponential phase of growth. Replicate flasks
were exposed either to cis-DDP, polyamines
or a combination of both.
After all drug treatments, flasks were
rinsed with Puck's saline, replenished with
fresh medium, and incubated at 37 5°C for
8 days to allow colony formation.
cis-DDP was obtained from the Drug
Synthesis and Chemistry Branch, Division of
Cancer Treatment, National Cancer Institute.
Polyamines were purchased from the Sigma
Chemical Company, St Louis, Missouri. Both
polyamines and cis-DDP were dissolved in
Hanks' Balanced Salt Solution (HBSS) and
diluted with complete growth medium before
cell exposure, except for spermine, in which
case calf serum was omitted from the growth
medium. Drug suspensions were made up
fresh on the day of the experiment.
RESULTS
Survival data for V79 hamster cells ex-
posed to cis-DDP and polyamines for
various periods of time and for graded
drug concentrations are shown in Figs 1-6.
Each Fig. represents data from a large
self-contained experiment using cells from
a common culture. Each experiment was
repeated at least 3 times, and the trends
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FIG. 1. Survival data for V79 hamster cells
exposed at 37 5°C for various time periods
to graded concentrations of cis-DDP.
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FIG. 2. Survival data for V79 hamster cells
treated for 2 h at 37 5°C with increasing
doses of cis-DDP in the presence (D-) or
absence (-) of 30mM putrescine.
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were consistent, but the data shown in
each Fig. represent a single representative
experiment. The reason for adopting this
policy is the general experience with in
vitro cell cultures that variations within an
experiment are much smaller than be-
tween experiments; this is particularly
true with chemotherapeutic agents, which
tend to vary from batch to batch. For each
treatment condition 4-6 replicate flasks
were used and the data points represent
the means. Survival curves were fitted to
the data by eye and standard errors
plotted only when they were larger than
the data point and were able to be seen on
the graph.
Survival data for V79 cells exposed at
37*50C to various concentrations of cis-
DDP for 1-6 h are shown in Fig. 1. Cell
survival is clearly dependent on both drug
concentration and duration of exposure.
An exposure to 100 vm ofcis-DDP for 1 h
produces about the same cell survival as a
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MG'r. 3.-Survivral (lata for V79 liamster cells
t,reat,ed for various timevs writl a fixed close
(20 HtM) of cis9-DDP, in t}se presence (A,
IO mm; *, ,30 mmr) or absenee ( *) of
pult,reseine?.
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FIG. 4. The effect of the sequence of treat-
ments with 30mM putrescine an(l cis-DDP
on cell survival. 0, cis-DI)P alone; 0,
putrescine before cis-DDP; V, putrescine
after cis-DI)P; O, simultaneous cis-DDP
anlll puitrescine.
6h exposure at 20 juM, a clinically relevant
dosage.
Fig. 2 comparestheeffecton cell survival
of a 2h exposure to various concentrations
of cis-DDP, with and without 30 mm
putrescine. The presence of the polyamine
considerably reduces the cytotoxicity of
the cis-DDP, at a concentration of
putrescine that was of itself non-toxic to
the cells.
The effect of two concentrations of
putrescine on the survival of cells exposed
to cis-DDP at a fixed concentration of
20 tM for various periods of time is shown
in Fig. 3. Protection against platinum
toxicity is evident for both concentrations
of polyamine (10 and 30 mM) for all
periods tested, the higher concentration of
putrescine being the more effective. The
data in Fig. 4 show how the temporal
sequence of the application of putrescine
and cis-DDP influences cell survival. Cells
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FIG. 5.-Survival data for V79 hamster cells
kept 4 h at 37 5°C, showing the toxic effects
of spermine on cells in medium containing
FCS. * Spermine alone; A spermi(liine
alon)e; * spermine +100 FCS.
were treated for 2 h with various concen-
trations of cis-DDP, the putrescine being
present for 2 h at 30 mivI, either before,
during or after exposure to platinum. The
data indicate clearly that the putrescine
must be present concurrently with the
cis-DDP to be effective as a protector.
The next two Figs, 5 and 6, show the
results of experiments with another of the
polyamines, spermine, The lowest curve in
Fig. 5 shows the progressive decline in cell
survival when cells are exposed to in-
creasing levels of spermine for a 4h period
in complete growth medium containing
10% FCS. The same is true of spermidine,
though the data are not shown in the
Figure. This toxicity is due largely to the
presence in calf serum of amine oxidase,
which oxidizes spermine to a toxic amino-
aldehyde (Tabor et al., 1964). This toxicity
can be avoided if the exposure of the cells
to the polyamine is carried out in serum-
free medium. This is illustrated for both
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FIG. 6.-Survival (lata foi V79 cells treate(l
for 2 h at 37 5°C with cis-DDP alone (*),
or in combination with 15,um spermine (0).
Serum-free medlium was use(l to avoid the
problem of toxic oxidlatioin products forme(d
by the inteiaction of spermine wAith FCS.
spermine and spermidine in the upper
curves ofFig. 5.
Fig. 6 shows the survival of cells ex-
posed for 2 h to graded concentrations of
cis-DDP in the presence or absence of
spermine. These treatments were carried
out in serum-free medium to avoid the
toxicity referred to above. It is clear that
spermine, like putrescine, affords sub-
stantial protection against cell killing by
cis-DDP.
DISCUSSION
These results show that the presence of
the polyamines putrescine and spermine
can significantly reduce the cytotoxicity
of the commonly used chemotherapy
agent cis-DDP. This holds true for high or
low drug concentrations, as well as ex-
tended exposures, which may be particu-
larly relevant to cis-DDP, which is known
to have a slow clearance time from tissues.
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These data may have important implica-
tions for clinical chemotherapy since it is
well established that polyamine levels may
be significantly higher during tumour
growth and regression (spermidine levels
rise significantly with tumour-cell kill).
Although it was shown by Heby &
Russell (1973) that methotrexate, cytosine
arabinoside and 5 azacytidine reduced
polyamine levels in the spleens of leuk-
aemic mice, their levels once again started
to rise significantly after about 8 days of
therapy. Chemotherapeutic drugs are
known to interfere with DNA, RNA, and
protein synthesis. In spite of this, there is
a lack ofdata relating increased polyamine
levelswithchemotherapeuticdrugtoxicity.
This can assume considerable importance
in the light of recent evidence by Rupniak
et al. (1980), who have shown that trans-
formed cells lacked polyamine growth-
regulatory mechanisms, and may not be
subject to the normal restraints of poly-
amine biosynthesis. Traditional studies of
in vitro drug toxicities may not then give
a complete picture of drug action, since
polyamines are absent.
The mechanism ofthe interaction ofthe
polyamines with cis-DDP is not clear at
present, but a number of hypotheses can
be advanced. cis-DDP is generally classi-
fied as an alkylating agent whose cytotoxic
effects results from interaction with DNA
or its constituents (Douple & Richmond,
1979) and it is possible that polyamines
may alter this effect since they are thought
to stabilize secondary structures ofnucleic
acids. Alternatively, polyamines are
thought to exert cell-membrane effects
(Schindler et al., 1980) and possibly this
could influence drug transport. This ex-
planation is less likely, however, since
similar studies done concurrently with
another chemotherapeutic drug, Bleo-
mycin, (unpublished) showed no effect of
polyamines on drug toxicity. Another
possibility may be that elevated levels of
polyamines could affect overall cell
kinetics and alter cell cycle distribution.
Our results raise questions as to the
effects of polyamines in combination with
some chemotherapeutic agents, since their
levels increase during a course of chemo-
therapy, and may adversely affect the
therapeutic ratio. The fact that this is
seen with cis-DDP warrants further in-
vestigation with other chemotherapeutic
agents.
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